GlassScriptPhysician profile
Margot A Waldman
NPI 1609287291
$7,295.72
in general payments reported to CMS, 2019-2025
36 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,629 · 2020: $479 · 2021: $432 · 2022: $1,864 · 2023: $1,752 · 2024: $988 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,438 · Food and Beverage: $930 · Education: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,438.40 |
| Food and Beverage | $929.77 |
| Education | $523.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,553.76 | 2019-2024 | Prostep, N/A, Augment Injectable |
| Treace Medical Concepts, INC. | $1,779.96 | 2020-2025 | |
| Smith+Nephew, INC. | $653.01 | 2019-2025 | Grafix Pl, Stravix, Hat-Trick |
| Mid-Atlantic Surgical Systems, LLC | $646.00 | 2019 | |
| Biotissue Holdings INC. | $168.10 | 2021 | |
| Horizon Therapeutics Plc | $142.06 | 2019-2022 | |
| Melinta Therapeutics, LLC | $121.24 | 2019 | |
| Abbott Laboratories | $118.63 | 2019-2021 | |
| Ossio INC | $115.21 | 2021-2022 | |
| Nevro Corp. | $104.18 | 2023-2024 | Senza |
| Wright Medical Technology, INC. | $92.61 | 2019 | |
| Triad Life Sciences INC. | $77.27 | 2022 | |
| Bioventus LLC | $61.91 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $61.84 | 2020-2022 | |
| Depuy Synthes Sales INC. | $57.38 | 2023-2025 | Motoband, Fibergraft Bg Morsels, Na |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $55.63 | 2025 | Senza |
| Paratek Pharmaceuticals, INC. | $50.98 | 2022-2023 | Nuzyra |
| Tactile Systems Technology INC | $41.61 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $38.10 | 2019-2020 | |
| Paragon 28, INC. | $37.48 | 2020-2023 | Mtp |
| Alfasigma USA, INC. | $35.84 | 2020 | |
| Assertio Therapeutics, INC. | $34.43 | 2019 | |
| Merck Sharp & Dohme LLC | $24.17 | 2019 | |
| Polarityte, INC. | $21.98 | 2019 | |
| Integra Lifesciences Corporation | $20.48 | 2021 | |
| Nabriva Therapeutics, Plc | $19.74 | 2020 | |
| Averitas Pharma INC. | $19.13 | 2025 | Qutenza |
| Novastep INC. | $19.11 | 2022 | |
| Axogen | $18.54 | 2019 | |
| Allergan, INC. | $18.34 | 2019 | |
| Medartis INC. | $16.62 | 2019 | |
| Medtronic, INC. | $15.97 | 2024 | Intellis Adaptivestim |
| Celularity INC. | $15.00 | 2019 | |
| Kerecis Limited | $14.30 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Kci USA, INC. | $13.29 | 2020 | |
| Hydrofera LLC | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margot Waldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.